We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
-12.58%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$43.6B
AUM Growth
-$9.03B
Cap. Flow
-$1.48B
Cap. Flow %
-3.4%
Top 10 Hldgs %
21.41%
Holding
1,190
New
110
Increased
278
Reduced
409
Closed
115

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$333M
2
XOM icon
ExxonMobil
XOM
+$242M
3
DLTR icon
Dollar Tree
DLTR
+$231M
4
NTR icon
Nutrien
NTR
+$213M
5
EYE icon
National Vision
EYE
+$198M

Sector Composition

Rank Sector Weight
1 Technology 22.53%
2 Healthcare 17.73%
3 Financials 14.85%
4 Consumer Discretionary 9.35%
5 Industrials 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNH
1151
CNH Industrial
CNH
$13.8B
-500,000
Closed -$7.93M
BERY
1152
DELISTED
Berry Global Group, Inc.
BERY
-707,850
Closed -$37.7M
FNA
1153
DELISTED
Paragon 28, Inc.
FNA
-400,000
Closed -$6.7M
PWUPU
1154
DELISTED
PowerUp Acquisition Corp. Unit
PWUPU
-2,100,000
Closed -$21.1M
MTAL.WS
1155
DELISTED
Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share
MTAL.WS
-395,600
Closed -$356K
THRX
1156
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
-761,589
Closed -$8.78M
SLGC
1157
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
-290,674
Closed -$2.33M
PACW
1158
DELISTED
PacWest Bancorp
PACW
-50,945
Closed -$2.2M
APGB.WS
1159
DELISTED
Apollo Strategic Growth Capital II Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
APGB.WS
-100,000
Closed -$58K
SHUAU
1160
DELISTED
SHUAA Partners Acquisition Corp I Unit
SHUAU
-900,000
Closed -$9.02M
ICPT
1161
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-100,000
Closed -$1.63M
PRPC.WS
1162
DELISTED
CC Neuberger Principal Holdings III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PRPC.WS
-209,950
Closed -$130K
DICE
1163
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
-30,000
Closed -$574K
XM
1164
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
-525,000
Closed -$15M
BLU
1165
DELISTED
BELLUS Health Inc.
BLU
-150,000
Closed -$1.03M
SPCMU
1166
DELISTED
Sound Point Acquisition Corp I, Ltd Unit
SPCMU
-1,500,000
Closed -$15.1M
TGR.U
1167
DELISTED
Kimbell Tiger Acquisition Corporation Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
TGR.U
-1,800,000
Closed -$18.2M
AUY
1168
DELISTED
Yamana Gold, Inc.
AUY
-7,000,000
Closed -$39.1M
NGC.WS
1169
DELISTED
Northern Genesis Acquisition Corp. III Redeemable Warrants, each whole warrant exercisable for shares of common stock at an exercise price of $11.50 per share
NGC.WS
-56,250
Closed -$27K
FSTX
1170
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
-900,000
Closed -$3.19M
SJI
1171
DELISTED
South Jersey Industries, Inc.
SJI
-250,000
Closed -$8.64M
ATAQ.WS
1172
DELISTED
Altimar Acquisition Corp III Warrants
ATAQ.WS
-47,793
Closed -$25K
NSTC.WS
1173
DELISTED
Northern Star Investment Corp. III Redeemable Warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTC.WS
-61,821
Closed -$27K
CLIM.WS
1174
DELISTED
Climate Real Impact Solutions II Acquisition Corporation Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
CLIM.WS
-16,320
Closed -$8K
SRRA
1175
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
-1,000,000
Closed -$32M

Similar funds

Adage Capital Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Adage Capital Partners held 1,190 positions worth $43.6B, down 17% from $52.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Adage Capital Partners withdrew a net $1.48B in Q2 2022, closing 115 positions and reducing 409 holdings. Its most notable exit was Nutrien, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Adage Capital Partners opened a new position in Booz Allen Hamilton worth $75.6M.

  • Adage Capital Partners's largest Q2 2022 buy was Booz Allen Hamilton: 837,064 shares worth $75.6M.
  • Adage Capital Partners added most to Biohaven Pharmaceutical Holding Company Ltd. in Q2 2022, an estimated $364M increase.
  • Adage Capital Partners's biggest Q2 2022 reduction was Royalty Pharma, cutting an estimated $333M.
  • Adage Capital Partners fully exited Nutrien in Q2 2022, selling an estimated $213M.
  • Adage Capital Partners's ten largest holdings make up 21% of its $43.6B portfolio in Q2 2022.
  • Adage Capital Partners opened 110 new positions and closed 115 in Q2 2022.
  • Adage Capital Partners's portfolio value fell 17% quarter-over-quarter to $43.6B.

Based on Adage Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.